3StocksOnFire — US Stock Trading Community · 451+ trades · 257% returns · 15,000 members · Main Site · Trader's Guide · Articles · Video Analyses
3 Stocks On Fire
3StocksOnFire Community Forum
Home Message Boards Trader's Guide Articles Video Analysis About Us Search Register

News:

Welcome to 3StocksOnFire! US stock trading community (2005-2010) with 451+ documented trades and 15,000+ members. View Portfolios | Stock Articles | Quotes

Main Menu

CVM - Sector: Healthcare---Industry: Biotechnology

Started by yabadabado, February 24, 2006, 08:30:14 PM

Previous topic - Next topic

yabadabado

Avg. $0.70

will hold all my shares, since it looks like it has more room to move.


flanders


Terliso

I bought some today... I feel this one will break soon on the upside.. I think 1 or 2 more candlestick will fit in that little Symmetrical Triangle... & BOOM... ;)

I'll put a tight stop on this I maybe wrong ;)

BULL POWER is strong, let's see...

Terliso

Calven, r u still in with this one?

calven

I dont think this one is going to break upwards but I could be wrong...reason being:

Stock shot up to 1.78
Retraced to 1.20 and gradually rose higher - on lower volume
This lower volume recovery candles seem weak to me...actually seems like bulls are losing their breath..I obviously could be wrong.

Still in (half position) but praying for news over the weekend or early next week. I dont think technicals are helping us here...

-cal  >:D
StockGravity.com - The Forces that Move Stocks!
http://www.stockgravity.com

nutsterrt

Picked some up on Friday, also with a tight stop. We'll see what happens  ::)

nutsterrt

Well...of course it dropped as soon as I bought it  ::). Pleased to see it making a bounce today on decent volume, thus far..

fous

CVM lookin nice today bouncing off long term support at 1.10, bouncing off the 61.8% fib retracement, and forming a text book morning doji star pattern. Im in at 1.26, Last AH quote i saw was up another 7.5%.

Anyone else still holding this rocket?

-fous

Morning Doji Star

Significance: bullish

Indication: reversal

# of candles: 3

Previous Trend: Bearish

The Morning Doji Star pattern is characterizes by 3 candles. The fisrt day is a long black candle reinforcing the already bearish downtrend. The second is gaps down and forms a doji candle, indicating confusion in the market and a reversal could be upon us. And finally the 3rd day forms a white candle whose closing price pushes well into the real body of the first black day that occurred in this pattern. A gap up on the 3rd day is preferred for an ideal bullish Morning Star pattern though is not required. Confirmation of this pattern is provided by a higher close on the 4th day.

Note: Candlestick reversal patterns are significantly more potent when occuring near areas of support and resistence.
trade it like you mean it!

Terliso

You got it right fousc... i still think this one will come up.. weekly MACD-Histogram still tracing up, i'll take that a sign that the pullback is done ;)

modest_investor

Hi Everyone,

This is my very first post and really enjoying this board.  Anyhow, I think I'm going in this on Monday as well.  Correct me if I am wrong but is this chart resembling a flag formation?  Is that one of the most bullish charts?

Thanks!

nutsterrt

fous-

Yeah, I'm still in. I was tempted to sell to cut losses, as I'd picked this up at around 1.50. Glad I didn't; really looking forward to seeing this pattern play out on monday. GLTA!


fous

Long: 1.26
Last: 1.28
Stop: 1.20
Target: $$

-fous
trade it like you mean it!

setravis

AP
Cel-Sci Shares Soar on Study News
Tuesday May 23, 5:40 pm ET 
Cel-Sci Says Drug Candidate Improves Long-Term Survival of Cancer Patients in Study


VIENNA, Va. (AP) -- Shares of biotechnology company Cel-Sci Corp. surged Tuesday on news of a successful mid-stage clinical trial of its cancer drug candidate Multikine.
In the Phase II study, the company measured long-term survival rates of patients who have undergone surgery for a head and neck cancer called oral squamous cell carcinoma.

 
Nearly 40 published studies between 1987 and 2004 show that the median survival rate 42 months after surgery for the disease is about 47 percent using standard of care treatment. CEL-SCI found the survival rate from standard of care treatment plus Multikine to be 67 percent.

The next step, a Phase III clinical trial, has already been approved. It would bring in a substantially larger pool of participants to further test the effectiveness of the treatment.

Head and neck cancer affects 500,000 people worldwide each year.

Cel-Sci stock gained 22 cents to close at $1.07 on the American Stock Exchange before adding 3 cents in after-hours trading. Shares have ranged between 44 cents and $1.78 over the past year.



"Success loves to hide behind challenges.
Embrace the challenge, enjoy the journey."

Do your own DD and invest based on your DD, not mine !

Semper Fi
S.E.Travis